Live from the NIH registry
Studies recruiting near Poughkeepsie right now
Top 25 of 77 recruiting studies, sorted by proximity — each links to its official registry page
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Cutaneous Melanoma, Stage II
N/A
Interventional 2,998 participants sought
Vassar Brothers Medical Center — Poughkeepsie, New York (0.4 mi)
· Sponsor: Melanoma and Skin Cancer Trials Limited
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Poughkeepsie, New York (0.4 mi)
· Sponsor: Medtronic
Assessment of CCM in HF With Higher Ejection Fraction
Heart Failure, Heart Failure With Preserved Ejection Fraction
N/A
Interventional 1,500 participants sought
Nuvance Health - Heart & Vascular Institute/Hudson Valley Cardiovascular Practice, PC — Poughkeepsie, New York (0.4 mi)
· Sponsor: Impulse Dynamics
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Vassar Brothers Medical Center — Poughkeepsie, New York (0.4 mi)
· Sponsor: NRG Oncology
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Local Institution - Unk077 — Rhinebeck, New York (16.0 mi)
· Sponsor: Mirati Therapeutics Inc.
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Hudson Valley Cardiovascular Practice PC — Poughkeepsie, New York (0.4 mi)
· Sponsor: Amgen
Tracking Results of Ablations to Combat AF Registry Generation 2
Atrial Fibrillation
N/A
Observational 10,000 participants sought
Vassar Brothers Medical Center — Poughkeepsie, New York (0.4 mi)
· Sponsor: AtriCure, Inc.
Examining the Most Effective Method to Reduce Running Ground Contact Time
Healthy Runners
N/A
Interventional 30 participants sought
Keller Army Community Hospital — West Point, New York (21.0 mi)
· Sponsor: Keller Army Community Hospital
Phase 2/3 Efficacy and Safety of PP405 in Adult Males
Androgenetic Alopecia
Phase 2, Phase 3
Interventional 600 participants sought
Vitality Clinical Trials LLC — Woodbury, New York (24.8 mi)
· Sponsor: Pelage Pharmaceuticals, Inc.
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Intracerebral Hemorrhage, Atrial Fibrillation
Phase 3
Interventional 700 participants sought
Vassar Brothers Medical Center — Poughkeepsie, New York (0.4 mi)
· Sponsor: Yale University
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Depressive Disorder, Major
Phase 3
Interventional 752 participants sought
Lucian Miron Manu MD Psychiatry PC — Woodbury, New York (24.8 mi)
· Sponsor: Janssen Research & Development, LLC
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Early Alzheimer's Disease
Phase 2
Interventional 340 participants sought
Mid Hudson Medical Research ( Site 1050) — New Windsor, New York (16.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 3
Interventional 530 participants sought
Westchester Putnam Gastroenterology — Carmel, New York (22.1 mi)
· Sponsor: Janssen Research & Development, LLC
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Proteinuric Kidney Disease
Phase 2
Interventional 74 participants sought
Research Site — Newburgh, New York (14.0 mi)
· Sponsor: Maze Therapeutics
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
Phase 3
Interventional 15,100 participants sought
Research Site — Poughkeepsie, New York (0.4 mi)
· Sponsor: AstraZeneca
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Poughkeepsie, New York (0.4 mi)
· Sponsor: Alnylam Pharmaceuticals
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Prostate Cancer
Phase 2
Interventional 900 participants sought
Hudson Valley Urology, PC — Poughkeepsie, New York (0.4 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Type 2 Diabetes
Phase 3
Interventional 55 participants sought
Cohen Children's Medical Center Division of Pediatric Endocrinology — Hyde Park, New York (6.2 mi)
· Sponsor: Eli Lilly and Company
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Vassar Brothers Medical Center — Poughkeepsie, New York (0.4 mi)
· Sponsor: NRG Oncology
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Melanoma, Glioma
Phase 1
Interventional 124 participants sought
Optum Medical Care, PC — Brewster, New York (25.9 mi)
· Sponsor: Pfizer
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 734 participants sought
Mid Hudson Medical Research, PLLC — New Windsor, New York (16.0 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Carmel, New York (22.1 mi)
· Sponsor: Hoffmann-La Roche
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Hudson Valley Cardiovascular Practice PC — Poughkeepsie, New York (0.4 mi)
· Sponsor: Duke University
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Heart Failure, Cardiorenal Syndrome
N/A
Interventional 320 participants sought
Nuvance Health — Poughkeepsie, New York (0.4 mi)
· Sponsor: Procyrion
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Vassar Brothers Medical Center — Poughkeepsie, New York (0.4 mi)
· Sponsor: SWOG Cancer Research Network